L-dopa therapy in parkinsonism: mechanism of action.
D000284:Administration, Oral; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis*; D006801:Humans; D008750:Methyldopa / Q000378:metabolism / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors
D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D004296:Dopa Decarboxylase; D004298:Dopamine